Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, chinese pharmacological society

    Chen, K; Zhang, X; Ke, X; Du, G; Yang, K; Zhai, S.
    Ther. Drug Monit; 40 (60), 2018
    BACKGROUND: Voriconazole (VRZ) is a second-generation triazole antifungal agent with broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily indicated for treating invasive aspergillosis. The most commonly used dose for adults is 4 mg/kg or 200 mg twice daily....
    Triazoles, Voriconazol/uso terapéutico, Antifúngicos/uso terapéutico, Antifúngicos, Aspergilosis Pulmonar Invasiva, Aspergilosis Pulmonar Invasiva/terapia, Aspergilosis Pulmonar Invasiva/tratamiento farmacológico
    Texto completo

    Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

    Ye, ZK; Chen, YL; Chen, K; Zhang, XL; Du, GH; He, B; Li, DK; Liu, YN; Yang, KH; Zhang, YY; Zhai, SD.
    J Antimicrob Chemother; 71 (11), 2016
    BACKGROUND: Guideline development should be based on the quality of evidence, balance of benefits and harms, economic evaluation and patients' views and preferences. Therefore, these factors were considered in the development of a new guideline for therapeutic drug monitoring (TDM) of vancomycin. OBJECTI...
    Antibacterianos, Vancomicina, Antibacterianos/uso terapéutico, Infecciones Bacterianas/tratamiento farmacológico, Monitoreo de Drogas/métodos, Vancomicina/uso terapéutico
    Texto completo